Facebook Twitter RSS
  • Search this Website
 
Skip to content
  • About Us
    • Our Vision
    • Intervention Strategies
    • Member – Government Committees
    • Annual Reports
    • Our Trustees
    • Donors
    • FCRA Information
  • Our Work
    • Pandemics and COVID-19
      • Helplines
      • Statements
      • High Court Order
      • Articles
      • Community Voices
      • Relief & Other Support for Covid-19
      • Intersectional Feminist Framework
      • Consultations on Gender, Equity & Covid-19 Vaccines
      • Webinar Series Pandemics & Public Health
      • Webinar Series on Vaccine Research & Access
      • Webinars on Covid-19
      • Videos and Podcasts
    • Public Health & Right to Health
    • Surrogacy & ARTs
      • Conference Participation & Seminars
      • Workshops & Discussions
      • Reports & Studies
      • Consultations
      • Film / Media
      • Policy Level Advocacy
      • Publications
      • Media Resources
    • Gender Based Violence
    • Sexual and Reproductive Health
    • Ethics in Clinical Trials, Access to Medicines
    • Young Women and Mental Health
    • Bioethics
    • Early Marriage and Health
    • Population Policies & Two Child Norm
  • Publications
    • Research Reports
    • Consultation Reports
    • Policy Briefs
    • Capacity Building Tools
    • Fact Finding Reports
    • Articles and Edited Volumes
    • Posters
    • Films & Videos
  • Archives
    • Clinical Trials
      • General
      • Affordability
      • Availability & Accessability
      • Compensation
      • Informed Consent
      • Recuritment
      • Bioethics
      • Guidelines & Legislations
  • Photo Gallery
  • Contact
  • Internship
  • Support Us

Category: Availability & Accessability

Post-trial access

  By admin Archives, Availability & Accessability, Clinical Trials

Pintail Usharani, Syed Mujtaba Hussain Naqvi | Perspectives in Clinical Research | PubMed Central (PMC) | NCBI | Jan-Mar 2013; 4(1): 58–60 Globalization of clinical research introduced several new challenges to the major stakeholders. These emerging aspects are dealt by regulators… Continue reading

At the end of the Clinical Trial: Does access to investigational technology end as well?

  By admin Archives, Availability & Accessability, Clinical Trials

Richard S. Saver | Western New England Law Review | Volume 31, Issue 2 | 2009 Medical research subjects increasingly are demanding (and litigating about) continued access to investigational technology after the clinical trial has concluded. The Article undertakes a… Continue reading

“We Have Our Protector”: Misperceptions of Protection Against HIV Among Participants in a Microbicide Efficacy Trial

  By admin Archives, Availability & Accessability, Clinical Trials

Joanne E. Mantell, Neetha S. Morar, Gita Ramjee | American Journal of Public Health | June 2006 | Source: NCBI-PubMed   Abstract Objectives We examined perceptions of the effectiveness and acceptability of a candidate microbicide among 94 South African female… Continue reading

Equitable treatment for HIV/AIDS clinical trial participants: a focus group study of patients, clinician researchers, and administrators in western Kenya

  By admin Archives, Availability & Accessability, Clinical Trials

D. N. Shaffer, V. N. Yebei, J. B. Ballidawa, J. E. Sidle, J. Y. Greene, E. M. Meslin, S. J. N. Kimaiyo, W. M. Tierney | Journal of Medical Ethics | January 2006 | Source: NCBI-PubMed A qualitative study with focus groups to describe the concerns… Continue reading

  • Announcements

    • Innovative practices to address GBV in the Asia Pacific region in the pandemic context 
    • Webinar: “Relooking local production and R&D: Why the TRIPS waiver is still relevant”
    • Short course: GBV & Health systems roles and accountability
    • Webinar on Intersectionality and Equity in Intellectual Property Rights in Healthcare
    • जेन्डर आधारित हिंसा (GBV) के मुद्दे पर कार्यशाला
  • What’s New

    • The Unravelling Pandemic: Envisioning our Intersectional Feminist Futures
    • Regulation of Surrogacy in India
    • Dignity in death or discrimination in death?
    • Exploring Intellectual Property and Access to Medicines from a Gender Approach
    • Short course: GBV & Health systems roles and accountability
  • Training, Building Capacities and Leadership

    Our Trainings and Capacity Building activities facilitate mobilization and provide support towards organizing around health issues and promoting health rights. They contribute to … Read more »

  • Research

    Research is an integral component of Sama’s work. Research is carried out on issues that the organization is already advocating around or in situations where we feel that there is a need to initiate … Read more »

  • Advocacy

    Sama recognizes the critical role of advocacy in building collective understanding on various issues and to strengthen and sustain campaigns around them. Advocacy initiatives of Sama, including … Read more »

  • Knowledge Creation

    Sama undertakes Creation of Knowledge Resources and their Dissemination on different issues pertaining to women and health. This forms our core strategy on various issues and initiatives that Sama … Read more »

  • About Us
  • Our Work
  • Publications
  • Archives
  • Photo Gallery
  • Contact
  • Internship
  • Support Us
© Sama – Resource Group for Women and Health, 2021
Powered by Parabola & WordPress.
Facebook Twitter RSS